CoChat

Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade

Open access
Chon, Hong Jae, Lee, Won Suk, Yang, Hannah, Kong, So Jung, Lee, Na Keum, Moon, Eun Sang, Choi, Jiwon, Han, Eun Chun, Kim, Joo Hoon, Ahn, Joong Bae, Kim, Joo Hang, Kim, Chan · 2019 · Clinical Cancer Research

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Abstract

Abstract Purpose: Cancer immunotherapy is a potent treatment modality, but its clinical benefit depends on the tumor's immune profile. Here, we used mJX-594 (JX), a targeted and GM-CSF–armed oncolytic vaccinia virus, as a strategy to remodel the tumor microenvironment (TME) and subsequently increase sensitivity to αPD-1 and/or αCTLA-4 immunotherapy. Experimental Design: The remodeling of the TME was determined using histologic, flow-cytometric, and NanoString immune profiling analyses. JX was intratumorally injected into implanted Renca kidney tumors or MMTV-PyMT transgenic mouse breast cancers with or without αPD-1 and/or αCTLA-4. Various combination regimens were used to evaluate immunotherapeutic anticancer responses. Results: Intratumoral injection of JX remodeled the TME through dynamic changes in the immune system, as shown by increased tumor-infiltrating T cells and upregulation of immune-related gene signatures. This remodeling induced conversion of a noninflamed tumor into an inflamed tumor. JX virotherapy led to enhanced abscopal effects in distant tumors, with increased intratumoral infiltration of CD8+ T cells. A depletion study revealed that GM-CSF is an indispensable regulator of anticancer efficacy of JX. Dual-combination therapy with intratumoral JX and systemic αPD-1 or αCTLA-4 further enhanced the anticancer immune response, regardless of various treatment schedules. Of note, triple combination immunotherapy with JX, αPD-1, and αCTLA-4 elicited the most potent anticancer immunity and induced complete tumor regression and long-term overall survival. Conclusions: Our results show that intratumoral JX treatment induces dramatic remodeling of the TME and more potently suppresses cancer progression with immune-checkpoint blockades by overcoming resistance to immunotherapy.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-18-1932

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 51 references

Cited by

See all 158

Metadata

Authors
Chon, H. J., Lee, W. S., Yang, H., Kong, S. J., Lee, N. K., Moon, E. S., Choi, J., Han, E. C., Kim, J. H., Ahn, J. B., Kim, J. H., & Kim, C.
Affiliations
  • Yonsei University (KR)
  • CHA University Bundang Medical Center (KR)
  • 4SillaJen, Inc., Seoul, Republic of Korea.
  • 2Laboratory of Translational Immuno-Oncology, Seongnam, Republic of Korea.
Corresponding author
Kim, Chan
Venue
Clinical Cancer Research
Published
2019-03-01
Volume
25
Issue
5
Pages
1612-1623
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2904883738
Cited by
158
References
52
Citations by year
2026: 7 · 2025: 11 · 2024: 28 · 2023: 18 · 2022: 23 · 2021: 36 · 2020: 28 · 2019: 7
FWCI
6.71
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Funders
  • National Research Foundation of Korea (NRF-2016R1C1B2014671)
  • National Research Foundation (NRF-2016M3A9E8941664)
  • MSIP MOHW (2015M3D6A1065644, HI15C3517)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
oncolytic vaccinia virus, tumor microenvironment remodeling, immune checkpoint blockade, anti-PD-1 therapy, CTLA-4 blockade, GM-CSF, intratumoral injection, abscopal effect, CD8+ T cells, tumor-infiltrating T cells, combination immunotherapy, immune-related gene signature
MeSH terms
Antineoplastic Agents, Immunological, Animals, Combined Modality Therapy, Disease Models, Animal, Genetic Vectors, Humans, Male, Mice, Transgenic, Models, Biological, Neoplasms, Biomarkers, Tumor, Vaccinia virus, Injections, Intralesional, Lymphocytes, Tumor-Infiltrating, Treatment Outcome, CD8-Positive T-Lymphocytes, Xenograft Model Antitumor Assays, Cell Line, Tumor, Oncolytic Virotherapy, Oncolytic Viruses, Mice, Immunomodulation, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-18-1932
The paper
Chon, H. J., Lee, W. S., Yang, H., Kong, S. J., Lee, N. K., Moon, E. S., Choi, J., Han, E. C., Kim, J. H., Ahn, J. B., Kim, J. H., & Kim, C. (2019). Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-18-1932

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.